Choice of medication should be determined case by case

Author(s):

Philadelphia-In about 80% of glaucoma cases, medication is the preferred initial approach for lowering IOP. However, the choice of medication must be made with the cognition of individual patient differences that can affect the tolerability and effectiveness of the drug, noted Marlene Moster, MD, clinical professor of ophthalmology, Thomas Jefferson Medical Col- lege, Philadelphia.

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!

Related Videos

Part 6: Biggest innovations in ophthalmology in 50 years

Part 5: Biggest innovations in ophthalmology in 50 years

Part 4: Biggest innovations in ophthalmology in 50 years

NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula

Part 3: Biggest innovations in ophthalmology in 50 years

(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025

Setting the stage in LA: Neda Shamie, MD, on the 19th Annual Controversies in Modern Eye Care

Part 2: Biggest innovations in ophthalmology in 50 years

Part 1: Biggest innovations in ophthalmology in 50 years

World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD

$(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD$

The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD

Choice of medication should be determined case by case

Newsletter